Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century

Budiharto, Tom; Musat, E.; Poortmans, Philip; Hurkmans, Coen; Monti, A.F.; Bar-Deroma, R.; Bernstein, Zvi; Tienhoven, Geertjan van; Collette, Laurence; Duclos, F.; Davis, B.; Aird, Edwin

doi:10.1016/j.radonc.2008.05.013

Cited by 39 publications

(21 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These guidelines were derived from the recommendations then in force in most European countries and were based on the actual situation, by no means reflecting the cancer incidence and population mix [15]. Similar figures are found across guidelines from other regions or regulatory agencies [16][17][18][19][20]. QUARTS did not make any firm recommendations regarding RTTs, because the available guidelines showed a large diversity and were mainly dependent on local habits, work distribution between the various disciplines and on treatment complexity [15].…”

Section: Discussionmentioning

confidence: 95%

Radiotherapy staffing in the European countries: Final results from the ESTRO-HERO survey

Lievens

Defourny

Coffey

et al. 2014

Radiotherapy and Oncology

View full text Add to dashboard Cite

The average personnel figures in Europe are now consistent with, or even more favourable than the QUARTS recommendations, probably reflecting a combination of better availability as such, in parallel with the current use of more complex treatments than a decade ago. A considerable variation in available personnel and delivered courses per year however persists among the highest and lowest staffing levels. This not only reflects the variation in cancer incidence and socio-economic determinants, but also the stage in technology adoption along with treatment complexity and the different professional roles and responsibilities within each country. Our data underpin the need for accurate prediction models and long-term education and training programmes.

show abstract

Section: Discussionmentioning

confidence: 95%

Radiotherapy staffing in the European countries: Final results from the ESTRO-HERO survey

Lievens

Defourny

Coffey

et al. 2014

Radiotherapy and Oncology

View full text Add to dashboard Cite

show abstract

“…In addition to using QUARTS [6] as a basis for guidelines, many countries refer to recommendations from other organisations such as IAEA [11], EFOMP [12], EORTC [13] and IPEM [14]. These recommendations seem to have been accepted as some kind of 'gold stan- dard' by the jurisdictions that use them.…”

Section: Discussionmentioning

confidence: 99%

“…24 of the responding 29 countries do have recommendations for staffing levels. These recommendations are mainly at the national level and may be based on recommendations from IAEA [11], EFOMP [12], EORTC [13] or national professional societies. As staffing levels are likely to be influenced by working hours, HERO sought information on this aspect of employment contracts.…”

Section: Equipmentmentioning

confidence: 99%

Guidelines for equipment and staffing of radiotherapy facilities in the European countries: Final results of the ESTRO-HERO survey

Dunscombe

Grau

Defourny

et al. 2014

Radiotherapy and Oncology

View full text Add to dashboard Cite

show abstract

“…The EORTC meanwhile has become established as a group responsible for the conduct of clinical trials, with the Radiation Oncology Group being the section which is responsible for radiotherapy trials. 28,52 Initial dosimetry audit in UK trials The CHART trial was the first UK trial to have an associated comprehensive audit programme with the emphasis on machinebased measurements. 22 This consisted of a full review (using a standard set of measurements) of one linear accelerator and simulator within each centre participating in the trial, performed at a visit to the centre by the QA team (therapy radiographer/ physicist/engineer).…”

Section: Dosimetry Audit In Clinical Trialsmentioning

confidence: 99%

Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials

Clark

Aird

Bolton

et al. 2015

BJR

View full text Add to dashboard Cite

Dosimetry audit plays an important role in the development and safety of radiotherapy. National and large scale audits are able to set, maintain and improve standards, as well as having the potential to identify issues which may cause harm to patients. They can support implementation of complex techniques and can facilitate awareness and understanding of any issues which may exist by benchmarking centres with similar equipment. This review examines the development of dosimetry audit in the UK over the past 30 years, including the involvement of the UK in international audits. A summary of audit results is given, with an overview of methodologies employed and lessons learnt. Recent and forthcoming more complex audits are considered, with a focus on future needs including the arrival of proton therapy in the UK and other advanced techniques such as four-dimensional radiotherapy delivery and verification, stereotactic radiotherapy and MR linear accelerators. The work of the main quality assurance and auditing bodies is discussed, including how they are working together to streamline audit and to ensure that all radiotherapy centres are involved. Undertaking regular external audit motivates centres to modernize and develop techniques and provides assurance, not only that radiotherapy is planned and delivered accurately but also that the patient dose delivered is as prescribed.

show abstract

Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century

Cited by 39 publications

References 23 publications

Radiotherapy staffing in the European countries: Final results from the ESTRO-HERO survey

Radiotherapy staffing in the European countries: Final results from the ESTRO-HERO survey

Guidelines for equipment and staffing of radiotherapy facilities in the European countries: Final results of the ESTRO-HERO survey

Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials

Contact Info

Product

Resources

About